| Name | Davutamig |
|---|
| Description | Davutamig (REGN-5093) is a humanized immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |